|
⚲
|
| Keyboard |
| Girao Tiago
✚
|
|
|---|---|
| CIK # | 0001618670 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001618670] | |
| 4 | [0001618670] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Health Sciences Acquisitions Corp | |
| Girao Tiago | |
| Landos Biopharma Inc | |
| Plus Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Health Sciences Acquisitions Corp IMVT
Common Stock
|
2025-05-01 | Grant | 208,388 | $0.00 | |
|
Health Sciences Acquisitions Corp IMVT
Stock Option (Right to Buy) · derivative
|
2025-05-01 | Grant | 293,505 | $0.00 | |
|
Landos Biopharma Inc LABP
Stock Option (right to buy) · derivative
|
2024-05-23 | Disposed to issuer | 1,800 | ||
|
Landos Biopharma Inc LABP
Stock Option (right to buy) · derivative
|
2024-05-23 | Disposed to issuer | 1,800 | ||
|
Landos Biopharma Inc LABP
Stock Option (right to buy) · derivative
|
2024-05-23 | Disposed to issuer | 1,800 | ||
|
Landos Biopharma Inc LABP
Stock Option (right to buy) · derivative
|
2023-05-23 | Grant | 18,000 | $0.00 | |
|
Landos Biopharma Inc LABP
Stock Option (right to buy) · derivative
|
2022-06-07 | Grant | 18,000 | $0.00 | |
|
Landos Biopharma Inc LABP
Stock Option (right to buy) · derivative
|
2022-05-16 | Grant | 18,000 | $0.00 | |
|
Landos Biopharma Inc LABP
Stock Option (right to buy) · derivative
|
2021-04-08 | Grant | 36,000 | $0.00 | |
|
Plus Therapeutics Inc CTYX
Subscription Rights (Right to Buy) · derivative
|
2018-07-25 | Option exercise | 1 | ||
|
Plus Therapeutics Inc CTYX
Warrants (Right to Buy) · derivative
|
2018-07-25 | Option exercise | 1,050 | ||
|
Plus Therapeutics Inc CTYX
Series C Preferred Stock · derivative
|
2018-07-25 | Option exercise | 1 | ||
|
Plus Therapeutics Inc CTYX
Subscription Rights (Right to Buy) · derivative
|
2017-11-28 | Option exercise | 1 | ||
|
Plus Therapeutics Inc CTYX
Warrants (Right to Buy) · derivative
|
2017-11-28 | Option exercise | 1,800 | ||
|
Plus Therapeutics Inc CTYX
Series B Preferred Stock · derivative
|
2017-11-28 | Option exercise | 1 | ||
|
Plus Therapeutics Inc CTYX
Incentive Stock Option (right to buy) · derivative
|
2017-03-08 | Grant | 42,000 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Subscription Rights (Right to Buy) · derivative
|
2016-06-15 | Option exercise | 5,667 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Warrants (Right to Buy) · derivative
|
2016-06-15 | Option exercise | 2,833 | ||
|
Plus Therapeutics Inc CYTX
Common Stock
|
2016-06-15 | Option exercise | 5,667 | ||
|
Plus Therapeutics Inc CYTX
Common Stock
|
2016-01-28 | Grant | 35,250 | $0.00 | |
| showing 20 of 26 most recent transactions | |||||